5-amino-1-methylquinolin-1-ium iodide:Exports & Compliance White Paper 2026

I. Executive Summary

5-Amino-1-methylquinolin-1-ium iodide (CAS 42464-96-0) is a quaternised quinoline salt of formula C10H11IN2 and molecular weight 286.12 g/mol, comprising an N-methyl quinolinium cation bearing a 5-amino substituent and an iodide counter-ion. The permanent positive charge, the extended heteroaromatic chromophore and the exocyclic amine make it a useful research intermediate for quaternary nitrogen heterocycles, dye and fluorophore-type scaffolds, and analytical method development. Its 2026 profile is that of a low-volume, high-documentation specialty: orders run from grams to a few kilograms, and value is created by impurity control rather than tonnage.

The compound has no approved therapeutic indication and is not a licensed medicine, food ingredient or consumer product. Material is supplied strictly as Research Use Only (RUO) reagent and research intermediate, not for human or veterinary use. What a competent CDMO sells alongside the substance is a control strategy: purge and control of residual methyl iodide under ICH M7 principles, assay of the iodide counter-ion, control of regioisomeric amino-quinoline species, and validated HPLC, LC-MS, NMR and ion-chromatography methods backed by a full certificate of analysis.

For procurement and compliance teams the decisive variables are the residual alkylating-agent specification and its validated headspace GC-MS method, iodide counter-ion content, regioisomeric purity of the 5-amino isomer, water content, colour and photostability on storage, ICH Q3D elemental limits, and documentation depth. Buyers who specify only an assay routinely receive material that passes on purity while failing on genotoxic-impurity expectations, the most common cause of rejection for this class of salt.

II. Product Deep Dive: Molecular Mechanisms and Production Evolution

2.1 Physicochemical Properties and Mechanisms

Quaternisation converts a neutral, distillable quinoline into a permanently charged, high-melting, water- and alcohol-soluble crystalline salt that cannot be handled as a free base. The cation is an extended conjugated heteroaromatic with an amino donor, giving strong UV absorption and environment-sensitive emission that make the scaffold attractive for probe and dye research, while the iodide anion is a heavy, polarisable, mildly reducing counter-ion with its own analytical and stability consequences.

• Permanent Cation and Salt Behaviour: The material exists only as a salt, so specifications must address counter-ion stoichiometry and identity rather than free-base assay, and reversed-phase methods generally require ion-pairing or high-aqueous mobile phases with careful control of peak shape. Hygroscopicity is significant, water content drives assay drift on a weight basis, and counter-ion exchange during downstream salt-forming steps is a design variable rather than an afterthought.
• Chromophore, Photostability and Iodide Oxidation: The quinolinium core absorbs strongly and can be photo- and thermally labile, and iodide is readily oxidised to iodine, producing yellow-to-brown discolouration that buyers read as a quality defect even when chromatographic purity is unchanged. Amber glass, low-oxygen headspace and refrigerated storage are therefore quality measures, not merely logistical preferences.

2.2 Synthesis and Manufacturing Technologies

The manufacturing sequence falls into three stages: construction and regioselective functionalisation of the quinoline nucleus, introduction of the 5-amino group, and N-quaternisation with a methylating agent to give the iodide salt. Route selection is governed by regioselectivity in electrophilic substitution on the quinoline ring, the genotoxic burden of nitro and alkylating reagents, and the ease of isolating a crystalline, low-residual-reagent salt. Discussion stays at the level of route class and control strategy.

• Core Construction and Regioselective 5-Amine Installation: Classical quinoline ring syntheses and modern cross-coupling-based approaches are both used to set the substitution pattern, with the 5-amino group typically installed through nitration followed by catalytic or chemical reduction. Regioselectivity is the central issue because 5-, 6-, 7- and 8-amino isomers are chromatographically similar; reduction choice also determines the metal-residue profile and the burden of nitro and arylamine impurity assessment.
• Quaternisation, Salt Formation and Alkylating-Agent Purge: N-methylation with methyl iodide is exothermic and must be run under controlled stoichiometry, temperature and solvent regime, with in-process control of conversion and of residual alkylating agent. Because iodomethane is a potent alkylating agent, the purification train is designed for documented purge: reaction-endpoint control, vacuum or sparge stripping, crystallisation purge studies and validated headspace GC-MS release testing, supported by a fate-and-purge rationale consistent with ICH M7.

2.3 Core Application Matrix

• Fluorophore and Dye-Scaffold Research: Quinolinium salts are classical precursors to polymethine and styryl-type chromophores, and this amino-substituted cation is used in exploratory dye and probe synthesis where an electron-donating substituent tunes absorption and emission. Supply is RUO and in-vitro only; no performance, diagnostic or clinical claim is made or implied.
• Analytical Reagent and Reference Material: The salt serves as an analytical standard for identity, retention and spectral-library work, and as a matrix for developing ion-pairing HPLC, LC-MS and ion-chromatography methods for quaternary heterocycles. Buyers value certified identity by NMR and HRMS, stated counter-ion content and documented homogeneity.
• Custom Intermediate for Quaternary Heterocycle Programmes: Development groups use it as a building block when a cationic, iodide-paired heteroaromatic is required, including salt-metathesis studies to other counter-ions. Here the CDMO deliverable is a documented route, impurity profile and scale-up path rather than a catalogue item.

III. Global Market Supply-Demand Landscape and Export Trends

3.1 Demand Drivers and Market Shifts

Demand tracks exploratory programmes in fluorescent probe and dye chemistry, materials research, and heterocyclic building-block catalogues, rather than any single industrial formulation. In 2026 two shifts dominate: buyers routinely impose ICH M7-style limits on residual alkylating agents for intermediates that may later feed regulated programmes, and they expect method-validation evidence rather than a purity statement. Both shift value from traders to CDMOs with analytical capability.

3.2 Capacity Distribution and Export Flows

Capacity is multipurpose and campaign-based. Chinese producers in Jiangsu, Shandong and Zhejiang supply quinoline heterocycle chemistry at competitive cost with short lead times; Indian contractors combine synthesis with strong LC-MS, NMR and ion-chromatography method groups; European and North American CDMOs serve buyers needing containment, audited quality systems or GMP campaigns. Export flow is parcel-based and air-freighted, with release testing setting the lead time.

3.3 Market Bifurcation and Pricing Dynamics

The market splits into catalogue RUO grade, custom-synthesised RUO with extended specifications, and GMP-grade development campaigns under ICH Q7 and Q11. Price differences largely reflect the cost of alkylating-agent control: validated headspace GC-MS testing, purge studies, segregation and cleaning verification. Quotations should be compared against the full specification, since two offers at identical purity can differ sharply in residual-reagent assurance.

IV. In-depth Analysis of Global Compliance and Regulatory Barriers

Compliance work for this salt concentrates on three fronts: ordinary chemical-control obligations for import and labelling, genotoxic-impurity expectations inherited from the quaternisation chemistry, and the RUO boundary that prevents the material from being presented as anything other than a research intermediate. Exporters should pair documented Know-Your-Customer checks with an end-use declaration and a written refusal policy for undocumented orders.

4.1 European Market: REACH, CLP, and Sector-Specific Directives

• REACH Registration and CLP Classification: Importers must verify whether the substance is registered for the intended tonnage band and appoint an Only Representative where necessary, since quaternary ammonium salts of this type are frequently outside existing registrations at research volumes. CLP classification must be derived from data or defensible read-across covering acute oral toxicity, irritation and aquatic hazard, and the label, safety data sheet and transport documentation must be consistent.
• Carcinogen and Mutagen Control for Alkylating Reagents: Residual methyl iodide is a suspected carcinogen with very low occupational exposure limits and is treated as a genotoxic impurity under ICH M7-style expectations during EU GMP inspections. Manufacturers must therefore document purge rationale, use validated trace-level methods, set specifications justified by acceptable-intake or threshold-of-toxicological-concern reasoning, and control worker exposure through closed charging, local exhaust and monitoring.

4.2 North American Market: TSCA, EPA, and FDA Regulations

• TSCA Inventory and EPA Reporting: Import for commercial purposes requires confirmation of TSCA inventory status or a valid exemption, plus assessment of EPA chemical data reporting and significant-new-use obligations. Research-and-development and low-volume exemptions are documentation-sensitive: the exemption must genuinely fit the shipment, and distributors selling from stock generally cannot rely on the buyer's research status.
• RUO Labelling and FDA Expectations: Because the material is supplied for research use, labels, catalogues and websites must state Research Use Only, non-human and non-veterinary use, and must avoid any diagnostic, therapeutic or clinical performance claim. Where the salt supports programmes that later become regulated, buyers expect ICH Q7-aligned starting-material documentation and, for GMP campaigns, a DMF-ready or CEP-supporting package.

4.3 The Critical Hurdle: Quality Control and Safety Limits

V. Green Trade Barriers and ESG in Manufacturing

Environmental performance is assessed at the campaign level. Buyers' questionnaires increasingly ask for ISO 14001 certification, solvent-recovery rates, halogenated waste treatment and iodine-cycle management, alongside ISO 9001 quality evidence. Since volumes are small, the practical differentiator is documented control of the methyl iodide and iodide streams rather than headline carbon intensity.

5.1 Carbon Footprint and Circular Economy

The dominant burdens are solvent use across multi-stage heterocycle synthesis, energy for vacuum stripping and drying, and cold-chain air freight of small parcels. Credible reductions come from solvent recovery by distillation, replacing chromatographic purification with crystallisation where the purge factor allows, and consolidating shipments. Scope 3 data remain immature in this segment, so buyers should engage suppliers on a data-improvement plan rather than expect verified primary emissions.

5.2 Sustainable Sourcing and Traceability

Traceability expectations cover the origin and lot of the quinoline precursor and methylating reagent, identification of any subcontracted nitration, reduction or quaternisation step, raw analytical data behind residual-reagent and counter-ion results, and manifests for halogenated waste and iodide-containing liquors. Documented chain of custody and audit rights should be written into the quality agreement; iodine recovery from mother liquors is both an economic and an environmental argument.

VI. Supply Chain Resilience and Export Logistics

Logistics risk is dominated by moisture uptake, light exposure and heat, all of which degrade appearance and assay before they degrade chromatographic purity. Because the salt is high-value per gram, insurance, tamper-evident sealing and temperature logging matter more than freight rate, and single-sourcing the analytical release laboratory is a recognised bottleneck during campaign peaks.

6.1 Packaging Standards and Moisture/Contamination Control

• Amber Glass, Desiccant and Refrigerated Cold Chain: Material should be packed in amber glass or inert-lined containers under nitrogen or dry inert headspace with desiccant, sealed tamper-evident and shipped refrigerated with a logged temperature indicator. This configuration suppresses water uptake and the iodide-to-iodine oxidation that produces the discolouration buyers treat as a rejection criterion.
• Segregation and Cross-Contamination Prevention: Because the substance is released against trace alkylating-agent limits, drums, liners and scoops must be dedicated or demonstrably cleaned, with sealed inner bags and documented cleaning verification where equipment is shared. Export packs should also carry an explicit RUO statement and documentation that prevents the material being mistaken for a finished or consumer-grade product.

6.2 Dangerous Goods Identification and Transit Protocols

Transport classification must be established from test data or defensible read-across before first shipment, since quaternary heteroaromatic salts vary from non-regulated goods to Class 6.1 toxic substances depending on acute-toxicity data, and the applicable UN entry, packing group and ADR, IMDG or IATA instruction follow from that determination. Where no classification applies, exporters still document the assessment, and customs-sensitive lanes should be pre-cleared with a complete end-use file.

VII. Enterprise Global Expansion Strategy Guide

Positions in this segment are won on the strength of the control strategy and the documentation, not on price. The priorities below reflect the criteria buyers apply when qualifying a supplier of quaternised, alkylating-agent-derived research intermediates.

1. Build a Genotoxic-Impurity Control Platform: Establish validated headspace GC-MS or LC-MS/MS methods at trace level, run documented purge-factor studies for methyl iodide and related alkylating species, and justify limits using ICH M7 acceptable-intake or threshold-of-toxicological-concern reasoning. Marketing this capability converts a hazardous-chemistry liability into a qualification asset.
2. Sell the Analytical Package and Method Transfer: Offer ion chromatography for iodide, quantitative NMR, HRMS identity, regioisomer resolution, water determination and residual-solvent profiling, then transfer methods to the customer's laboratory with a validation report. Suppliers whose data are accepted without re-testing win repeat campaigns and longer-term development agreements.
3. Tier RUO and GMP Supply with KYC Discipline: Maintain a fast RUO catalogue grade and a documented ICH Q7 and Q11 development path toward GMP material, with explicit change control between them, and pair both with Know-Your-Customer verification, signed end-use declarations and written refusal of undocumented orders.

VIII. Conclusion

5-Amino-1-methylquinolin-1-ium iodide is a technically demanding small-volume specialty whose commercial value is set by control of residual alkylating agent, counter-ion stoichiometry and regioisomeric purity. Suppliers that can demonstrate purge science, trace-level analytics, containment discipline and cold, light-protected logistics will continue to displace traders, because research and development buyers increasingly qualify the control strategy before they qualify the molecule.

The compound has no approved therapeutic indication and must be labelled, sold and documented as Research Use Only material, not for human or veterinary use and not a finished consumer product. Within that boundary it is a legitimate subject of CDMO work spanning heterocyclic synthesis, quaternisation process design, genotoxic-impurity control and method validation. Buyers who fix the residual-reagent limit and counter-ion assay at enquiry stage achieve shorter qualification cycles and fewer disputes.

IX. Industry Resource Connection and Supplier Ecosystem

Powered by Guidechem

This white paper is exclusively compiled by the Guidechem Intelligence Team based on global customs data, regulatory databases, and industry research. Guidechem is a leading global B2B chemical platform, dedicated to connecting global buyers with verified, high-quality manufacturers.

Guidechem Global 5-amino-1-methylquinolin-1-ium iodide Supplier Ecosystem List

Relying on Guidechem's extensive global database, we have mapped the core participants in the current global 5-amino-1-methylquinolin-1-ium iodide supply chain:

• China Heterocycle and Quaternisation Cluster: Jiangsu, Shandong and Zhejiang producers offer quinoline ring construction, nitration and reduction, and N-methylation in multipurpose kilo-lab and pilot suites, supported by dense local supply of quinoline precursors and methylating reagents. Strengths are speed, cost and flexible scale; buyers should verify trace-level alkylating-agent testing, purge documentation and halogenated waste handling.
• India CRAMS and Analytical Services Hub: Contractors in Hyderabad, Bengaluru and Ahmedabad combine custom heterocycle synthesis with strong LC-MS, NMR, ion chromatography and headspace GC-MS capability, and are practised in ICH M7 purge studies and ICH-aligned documentation. Audit familiarity and English-language reporting make them a strong second source for development campaigns.
• Europe High-Containment and GMP-Ready Specialists: Western European CDMOs provide occupational hygiene expertise, health-based exposure limit derivation, occupational exposure banding and GMP-grade campaigns with DMF or CEP support. They are preferred where containment, audit readiness or regulated documentation outweigh unit cost, and typically run the strictest end-use screening.